Eurofins Viracor introduces BKV inSIGHT T-cell immunity panel for BK virus immune monitoring in kidney transplant patients

GSK's Jideytro (zidesamtinib) gains US approval for previously treated ROS1-positive NSCLC

Hugel Aesthetics expands US presence

European Commission expands Crysvita approval to infants with XLH

AbelZeta's C-CAR168 receives EMA PRIME designation for Lupus Nephritis and Systemic Lupus Erythematosus

Camurus' FDA accepts CAM2029 NDA resubmission for acromegaly, sets December decision date

Vanda Pharmaceuticals reports positive EMA opinion on orphan drug designation for imsidolimab in generalised pustular psoriasis

World Health Organization approves 'codabakalner' as International Nonproprietary Name for Spinogenix's SPG601

Lakewood-Amedex Biotherapeutics reports positive Nu-3 Gel preclinical safety data for upcoming Phase 2a trial

MAXONA Pharmaceuticals' Phase 2 clinical trial IND application for MAX-001 cleared by US FDA

FDA grants priority review to Genentech's Gazyva for primary membranous nephropathy

AstraZeneca signs global licence deal with Dizal for lung cancer drug Zegfrovy

Summit Therapeutics sells Phase III antibiotic asset ridinilazole to Biossil

European Commission approves Erbitux combination for first-line BRAF V600E-mutant mCRC

US FDA accepts BioMarin's sNDA for full approval of VOXZOGO (vosoritide) for children with achondroplasia